Aug 13, 2020
Three Lakes Foundation and MATTER to hold an Innovation Challenge for Pulmonary Fibrosis
May 25, 2020
OFEV® (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases (PF-ILD)(1)
Apr 06, 2020
Pulmonary Fibrosis Foundation Statement on COVID-19
Mar 23, 2020
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
Mar 17, 2020
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus
Mar 09, 2020
FDA approves Ofev® as first treatment for chronic fibrosing ILDs with a progressive phenotype
Mar 04, 2020
Pulmonary Fibrosis Foundation Launches Industry Consortium To Identify Biomarkers In Pulmonary Fibrosis
Feb 13, 2020
Promedior Announces Completion of Acquisition by Roche
Feb 06, 2020
PharmaNest Announces Kidney and Lung Fibrosis Quantification Data to Be Presented at the 2020 Fibrosis and Tissue Repair Keystone Symposium
Jan 14, 2020
Rx Globally Patented Non-Steroidal Nasal Spray for All Lung Diseases including Pulmonary Fibrosis, CF, COPD, Unmet Needs with No Known Side Effects that can also be used to Deliver Antivirals, Antimicrobials, Insulin, and other Drugs
Jan 09, 2020
Visiongain Report Claims There is Huge Potential Within the $5.9bn Anti-Idiopathic Pulmonary Fibrosis Drugs Market
Dec 12, 2019
New Pulmonary Rehabilitation Program is a Breath of Fresh Air for Those With Chronic Lung Disease
Nov 20, 2019
New Report Reveals Major Gaps in Quality of Care for Canadians with Rare Lung Disease
Nov 15, 2019
Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
Nov 11, 2019
Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965
Nov 07, 2019
New analysis of patients with autoimmune-related ILDs in the INBUILD study shown as poster presentation at the 2019 ACR/ARP Annual Meeting
Nov 04, 2019
NIH Awards Major Grant In Pulmonary Fibrosis Research
Oct 31, 2019
Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019
Oct 21, 2019
Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
Oct 15, 2019
Pliant Therapeutics Announces Publication Demonstrating Feasibility of Positron Emission Tomography (PET) Tracers for Imaging Fibrosis in Patients with Idiopathic Pulmonary Fibrosis